VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...

Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development for ...

Based on its sound industrial ecosystem and strong policy support, Zhangjiang Pharma Valley in Shanghai is witnessing ...

BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today ...

(TWSE: 7827) is taking another step to broaden the development path for HCB101, its lead oncology asset, through a new partnership with InxMed. The Taiwan-listed clinical-stage biotech announced that ...

Virax Biolabs (VRAX) shares exploded higher on Thursday morning after management announced a lucrative cross-border ...

CAMBRIDGE, Mass., July 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative ...

As the United States marks the 250th anniversary of its independence, African policymakers have an opportunity to look beyond ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 ...

Anthropic announced the creation of its new Claude Science tool, which aims to help scientists speed up the drug development ...